SPEED BioSystems TURBO293 Transfection Reagents

Closed Solicitation Posted

Solicitation number
NOI-NIAID-24-2227854
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20814, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Paragraph 1:

The National Institute of Allergy and Infectious Diseases (NIAID) intends to award a sole-source, firm-fixed price purchase order for TURBO293 Transfection Reagents from SPEED BioSystems, LLC. The agency requires these reagents to meet continuity protocols and compatibility requirements for its operations. NIAID will evaluate any responses from interested vendors solely to determine if the procurement should be conducted competitively. Vendors must submit a capabilities statement, including past performance, by July 20, 2024 to be considered.

Paragraph 2:

This procurement is not set aside for any particular business size or socioeconomic status. SPEED BioSystems, LLC is the sole owner, developer, and seller of the required reagents and is identified as a small business. The purchase order will be for 78 units of the TURBO293 Transfection Reagents (20ML), to be delivered FOB Destination to the Vaccine Research Center in Bethesda, MD. The North American Industry Classification System (NAICS) code for this acquisition is 325414 - Biological Product (except Diagnostic) Manufacturing.

Notice text

This is a Notice of Intent (NOI). This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive quotes. 

The National Institute of Allergy and Infectious Diseases (NIAID) intends to award a firm-fixed priced, sole source, purchase order to SPEED BioSystems, LLC. 900 Clopper Road, Suite 130, Gaithersburg, MD 20878. 

TURBO293 TRANSFECTION REAGENT (20ML) QTY 78 
CAT # - PXX1002
Shipping location: FOB DESTINATION
Vaccine Research Center
BLDG 40
40 Convent Drive
Bethesda, MD 20814

The North American Industry Classification (NAICS) code for this acquisition is 325414 Biological Product (except Diagnostic) Manufacturing, with a business size standard of 1250 employees. SPEED BioSystems, LLC. is a small business.  

This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government intends to award a purchase order for this requirement after the end of this notice.

While this combined synopsis/solicitation does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that SPEED BioSystems, LLC is the sole owner, developer, and seller of the required reagents currently being utilized by NIAID per continuity protocols and compatibility requirement. However, vendors that believe they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact prior to the closing date and time of this notice. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement on NOI-NIAID-24-2227854 

This notice does not obligate the Government to award a purchase order or otherwise pay for any information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. 

For additional information or to submit responses, please contact Diana Rohlman, Contracting Specialist at diana.rohlman@nih.gov  
 

Similar open opportunities

Opportunity Agency Set-aside Responses due
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
NOI - 4D-Nucleofector Core Unit and X Unit NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
Preventative Maintenance and FullCare Service Support for Cytiva Sepax C-PRO Cell Separation Systems Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity